(Total Views: 630)
Posted On: 04/29/2020 11:41:19 PM
Post# of 148908
Thanks for posting this RTB...
Even though it was about today's developments with another drug, that was a nice excerpt for Leronlimab with Dr. Patterson... I'm sure he gave a number of other quotes and information but of course when it's a produced news story like that there's just so much that actually gets into the report.
But those are the kind of reports the mainstream news media should be doing with the various companies/drugs working on Covid-19... especially the ones in FDA trials that are finding success. And btw, IncellDx (CytoDyn) doesn't pay to get its message out in these type of reports...
Even though it was about today's developments with another drug, that was a nice excerpt for Leronlimab with Dr. Patterson... I'm sure he gave a number of other quotes and information but of course when it's a produced news story like that there's just so much that actually gets into the report.
But those are the kind of reports the mainstream news media should be doing with the various companies/drugs working on Covid-19... especially the ones in FDA trials that are finding success. And btw, IncellDx (CytoDyn) doesn't pay to get its message out in these type of reports...
Quote:
Bruce Patterson is CEO of IncellDx in San Carlos. He is also a virologist.
"I don't think you can piecemeal one positive report and one negative report and make broad conclusions about either," Dr. Patterson said.
His company is preparing to release results of a study of a drug, leronlimab, he says reduces COVID-19's viral load and restores the immune system.
(1)
(0)Scroll down for more posts ▼
